SCHEMBL20899657

SCHEMBL20899657

NS(=O)(=O)c1ccccc1-c1ccsc1-c1sccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 1/20 0.45
CES1 P23141 1/20 0.43
PABPC1 P11940 1/20 0.40
DNMT1 P26358 1/20 0.40
STAT3 P40763 1/20 0.40
CA2 P00918 6/20 0.37
CA7 P43166 4/20 0.37
CA1 P00915 5/20 0.37
CA6 P23280 4/20 0.37
CA12 O43570 4/20 0.37
CA9 Q16790 4/20 0.37
CA4 P22748 3/20 0.37
CA5A P35218 3/20 0.37
CA5B Q9Y2D0 3/20 0.37
CA14 Q9ULX7 2/20 0.37
CYP2C9 P11712 1/20 0.37
PTGES2 Q9H7Z7 3/20 0.36
CA3 P07451 2/20 0.36
PTGS1 P23219 2/20 0.35
PTGS2 P35354 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1080972 0.74 CA2 (0.61) STAT3CA2CA7CA1CA6
SCHEMBL20899666 0.73 CYP2A6 (0.48) STAT3CA2CA1CA12CA9
SCHEMBL28407818 0.73 CA2 (0.47) PTPRCCA2CA7CA1CA6
SCHEMBL8347239 0.72 CA2 (0.58) PTPRCCES1STAT3CA2CA7
SCHEMBL3248283 0.71 PTGS1 (0.63) PTPRCPTGS1PTGS2
SCHEMBL6820364 0.69 CA2 (0.50) STAT3CA2CA7CA1CA6
SCHEMBL6512541 0.68 PTPRC (0.46) PTPRCCES1PABPC1DNMT1STAT3
SCHEMBL9773297 0.67 RAB9A (0.47) PTPRCCES1KDM4ENPC1RAB9A
SCHEMBL3478457 0.67 SCN9A (0.49) STAT3CA2CA7CA1CA6
SCHEMBL15637602 0.67 PTPRC (0.47) PTPRCCES1KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019075394-A1 COMPOUNDS FOR TREATMENT OF EMOTIONAL/PSYCHOLOGICAL SYMPTOMS IN FRAGILE X SYNDROME VANDERKLISH PETER (US) 2019-04-18 WO disclosed